Cancer Therapies Flashcards
Targeting HER2
Transtuzumab
Pertuzumab
Lapatinib
Targeting EGFR
Cetuximab
Panitumab
Erlotinib
Gefitinib
Targeting B-Raf V600E
Vemurafenib
Inhibit VEGF signalling
Aflibercept
Sorafenib
Sunitinib
Bevacuzimab
PARP inhibtors
Olaprib
Nirparib
Novel therapies
Cytokines
Immunomodulators
Monoclonal antibodies
Cytokines
Interleukin 2
Interfeuron alpha
Immunomodulators
Thalidomide
Lenalidomide
Pomalidomide
Checkpoint blockade methods
CTL4 inhibition
PD1 and PDL1 indibition
Checkpoint blockade (CTL4-A inhibitor)
Ipilumumab
Checkpoint blockade (PD1 and PD-L1)
Pembrolizumab
Nivolumab
Atezolizumab
Protosome inhibitors
Bortezomib
Carfilzomib
Ixazomib
Targeted therapies
Proteosome inhibitors Protein kinase inhibitors Hedgehog pathway inhibiors VEGF inhibitor PARP inhibitors BCl2 inhibitors
Protein kinase inhibitor
Imatanib
Hedgehog pathway inhibitor
Vismodegib
Bcl2 inhibitor
Venetoclax